Form 4 for AURA Aura Biosciences, Inc.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0000950170-25-049279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-02 | 2025-03-31 | AURA | Bitetti Teresa Marie | Dir | A - Grant | $0.00 | +21.0K | 21.0K | New | $0 |
| D | 2025-04-02 | 2025-03-31 | AURA | Bitetti Teresa Marie | Dir | A - Grant | $0.00 | +29.0K | 29.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | A | A | 21,000 | $0.00 | 21,000 | D | — | — | (F1) These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on April 15, 2026, subject to the Reporting Person's continued service as of each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-03-31 | A | A | 29,000 | $0.00 | 29,000 | D | $5.86 · — to 2035-03-31 | 29,000 Common Stock | (F2) The shares underlying this option vest in three substantially equal annual installments beginning on March 31, 2026, subject to the Reporting Person's continued service as of each such vesting date. |